Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Retatrutide has not received marketing authorisation from the MHRA or EMA and is not available through NHS prescribing pathways
Global GLP-1 receptor agonist market is expected to witness lucrative growth over the forecast period as increasing number of patients are opting for GLP-1 drugs due to their greater efficacy and lesser side effects compared to conventional diabetes medications
Hyperinsulinemia associated depression
Side effects can persist after a dose change Because GLP1 levels taper gradually rather than dropping to zero, symptoms can continue for days or even weeks after a dose change
These medications include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity)
Baseline blood work before starting Before your first dose of any GLP-1 medication, get baseline blood work that includes a complete blood count, comprehensive metabolic panel, ferritin, serum iron, total iron binding capacity, zinc, vitamin D (25-OH), B12, folate, TSH, free T3, free T4, and hemoglobin A1c
